1-3 of 3
Branko Cuglievan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia

Open Access
Clinical Trials & Observations
Olayinka Okeleji, David McCall, Amber Gibson, Miriam B. Garcia, Cesar Nunez, Michael Roth, Jeremy Connors, Demetrios Petropoulos, Priti Tewari, Branko Cuglievan, Irtiza N. Sheikh
Journal: Blood Advances
Blood Adv (2025) 9 (8): 1988–1990.
https://doi.org/10.1182/bloodadvances.2024015527
Published: 2025
Journal Articles

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

Free
Christopher J. Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca J. Deyell, Jamie E. Flerlage, Anna K. Franklin, Jennifer Krajewski, Kasey J. Leger, Lianna J. Marks, Robin E. Norris, Martha Pacheco, Faye Willen, Adam Paul Yan, Paul D. Harker-Murray, Lisa Giulino-Roth
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3225–3231.
https://doi.org/10.1182/bloodadvances.2022009323
Published: 2023
Includes: Supplemental data
Journal Articles

Gilteritinib combination therapies in pediatric patients with FLT3 -mutated acute myeloid leukemia

Free
David McCall, Michael Roth, Kris M. Mahadeo, Laurie Toepfer, Cesar Nunez, Nicholas J. Short, Naval Daver, Tapan M. Kadia, Courtney DiNardo, Joanna S. Yi, Branko Cuglievan
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5215–5219.
https://doi.org/10.1182/bloodadvances.2021005164
Published: 2021